NEW

CenTrak Offers Consulting, Training Services

CenTrak has announced the launch of CenTrak Engage. A new release describes CenTrak Engage as “ new expert-led consulting and training services providing a tailored, multi-tiered assessment and transformation program to health care systems. Through practical guidance,...

Countertop Medication Dispensing Cabinet Announced

As part of a line extension, TouchPoint Medical has released a new countertop model of its F series automated medication dispensing cabinet. Any facility that is short on space or budget will benefit from the countertop model, according to a news release. Medication...

Encompass Group Brings eMax Replacement Surfaces to Acute Care

Encompass Group LLC is bringing its line of eMax Replacement Support Surfaces to the acute care market. “With the overwhelmingly positive reception acute care has given our Airisana Therapeutic Support Surface we’re expanding our product offerings in this important...

Getinge clarifies FDA Medical Device recall communication

Following the FDA communication to healthcare providers on June 2, Getinge reinforces guidance that no devices mentioned in the Field Safety Notice need to be returned. On June 8, 2022, FDA revised their published press release, FDA Medical Device Recalls: Atrium...

JointMedica’s Polymotion Hip Resurfacing System Granted Breakthrough Device Designation

JointMedica’s Polymotion Hip Resurfacing System

Exactech has announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion Hip Resurfacing System.

Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United Kingdom-based orthopaedic device designer and manufacturer to deliver the next generation of hip resurfacing to the global market and holds exclusive global distribution rights to the product.

“This designation by the FDA is a validation of our core belief at JointMedica – that our hip resurfacing device addresses an acute unmet need of relatively younger, active hip arthritis patients,” said Terence Smith, managing director of JointMedica.

The Breakthrough Devices Program is a voluntary program for certain medical devices and device-led combination products that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.

With more than three decades of experience using hard-on-hard articulations in hip resurfacing, Derek McMinn MD, FRCS, and Ronan Treacy, MD, FRCS, designed the Polymotion Hip Resurfacing System to leverage the clinically successful design principles of their previous hip resurfacing devices, now with advanced polyethylene and titanium manufacturing technology. The Polymotion hip offers the biomechanical benefits of hip resurfacing but eliminates metal-on-metal articulating surfaces.

Previous

Next

Submit a Comment

Your email address will not be published.

X